| Literature DB >> 36076729 |
Mariana Buranelo Egea1,2, Gavin Pierce2, Si-Hong Park2, Sang-In Lee2, Fabienne Heger3, Neil Shay2.
Abstract
The pseudofruit of A. othonianum Rizzini, "Cerrado" cashew pulp, has been described as rich in flavonoids, phenolic compounds, and vitamin C. The objective of this work was to evaluate the beneficial health effects seen with the addition of "Cerrado" cashew pulp (CP) to an obesogenic high fat diet provided to C57BL/6J male mice. In week 9, the HF-fed group had a significantly higher baseline glucose concentration than the LF- or HF+CP-fed groups. In RNAseq analysis, 4669 of 5520 genes were found to be differentially expressed. Among the genes most upregulated with the ingestion of the CP compared to HF were Ph1da1, SLc6a9, Clec4f, and Ica1 which are related to glucose homeostasis; Mt2 that may be involved steroid biosynthetic process; and Ciart which has a role in the regulation of circadian rhythm. Although "Cerrado" CP intake did not cause changes in the food intake or body weight of fed mice with HF diet, carbohydrate metabolism appeared to be improved based on the observed changes in gene expression.Entities:
Keywords: Anacardium othonianum Rizz; cashew fruit; functional foods; obesity
Year: 2022 PMID: 36076729 PMCID: PMC9455023 DOI: 10.3390/foods11172543
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Final body weight (A), Average weight gain (B), Food efficiency (C), Liver weight/body weight (D), Kidney weight/ body weight (E), and Adipose tissue weight/body weight (F) in male C57BL/6J mice fed a low fat (LF) diet, a high fat (HF) diet, or a HF plus cashew pulp (HF+CP) diet for 10 weeks. a, b Groups not sharing the same lowercase letters indicate that one-way ANOVA found significant differences between groups (p < 0.05). Average (n = 12 for control groups and n = 8 for experimental group) ± SEM.
Figure 2Fasting glucose (A) and Serum MCP-1 concentration (B) in male C57BL/6J mice fed a LF diet, HF diet, or a HF+CP HF+CP diet for 10 weeks. a, b Groups not sharing the same lowercase letters indicate that one-way ANOVA found significant differences between groups (p < 0.05). Average (n = 12 for control groups and n = 8 for experimental group) ± SEM.
Figure 3Total triacylglycerol (TAG) assay (A) and study hematoxylin-eosin stained liver cross sections of male C57BL/6J mice fed a LF diet (B), a HF diet (C), or a HF+CP diet (D) for 10 weeks. Slides were observed under 400 magnification (40× objective) using an Olympus IX71 light microscope (Olympus America, Center Valley, PA, USA). One-way ANOVA indicated significant differences between diet groups (p < 0.05). a, b Groups not sharing the same lowercase letters indicate that one-way ANOVA found significant differences between groups (p < 0.05). Average (n = 12 for control groups and n = 8 for experimental group) ± SEM.
Figure 4Venn diagram with gene expression of liver of male C57BL/6J mice fed either a LF diet or HF+CP.
Canonical pathways enriched for induced the down-regulated and up-regulated genes of liver from male C57BL/6J mice fed HF+CP.
| Pathway | #Total | #Up | #Down | Significance | ||
|---|---|---|---|---|---|---|
| 1 | Complement Activation, Classical Pathway | 8 | 7 | 1 | 3.46 | 0.000 |
| 2 | Cytoplasmic Ribosomal Proteins | 21 | 4 | 17 | 3.45 | 0.000 |
| 3 | G Protein-coupled Receptor (GPCR) | 11 | 3 | 8 | 2.77 | 0.002 |
| 4 | Complement and Coagulation Cascades | 16 | 14 | 2 | 2.64 | 0.002 |
| 5 | MAPK Cascade | 9 | 5 | 4 | 2.3 | 0.005 |
| 6 | Odorant GPCR | 14 | 8 | 6 | 2.17 | 0.007 |
| 7 | Non-odorant GPCR | 18 | 8 | 10 | 2.13 | 0.007 |
| 8 | MAPK signaling pathway | 29 | 18 | 11 | 1.74 | 0.018 |
| 9 | Metapathway biotransformation | 8 | 6 | 2 | 1.72 | 0.019 |
| 10 | Nuclear receptors in lipid metabolism and toxicity | 8 | 7 | 1 | 1.69 | 0.021 |
| 11 | TYROBP Causal Network | 13 | 12 | 1 | 1.65 | 0.022 |
| 12 | MAPK signaling pathway | 30 | 21 | 9 | 1.64 | 0.023 |
| 13 | Microglia Pathogen Phagocytosis Pathway | 10 | 10 | 0 | 1.61 | 0.025 |
| 14 | Robo4 and VEGF Signaling Pathways Crosstalk | 3 | 3 | 0 | 1.6 | 0.025 |
| 15 | miRNAs involved in DNA damage response | 1 | 1 | 0 | 1.59 | 0.026 |
| 16 | Glycolysis and Gluconeogenesis | 1 | 1 | 0 | 1.58 | 0.026 |
| 17 | Novel Jun-Dmp1 Pathway | 7 | 5 | 2 | 1.55 | 0.028 |
| 18 | Mitochondrial LC-Fatty Acid Beta-Oxidation | 5 | 3 | 2 | 1.48 | 0.033 |
| 19 | PPAR signaling pathway | 16 | 11 | 5 | 1.41 | 0.039 |
| 20 | Fatty Acid Beta Oxidation (streamlined) | 8 | 5 | 3 | 1.32 | 0.047 |
| 21 | Toll-like receptor signaling pathway | 18 | 13 | 5 | 1.23 | 0.058 |
| 22 | Steroid Biosynthesis | 4 | 4 | 0 | 1.23 | 0.059 |
| 23 | Focal Adhesion | 32 | 22 | 10 | 1.19 | 0.064 |
| 24 | GPCRs, Class A Rhodopsin-like | 18 | 9 | 9 | 1.19 | 0.065 |
| 25 | Eicosanoid Synthesis | 5 | 4 | 1 | 1.18 | 0.066 |
Top 25 upregulated and downregulated genes of liver from male C57BL/6J mice fed HF+CP after 10 weeks. FC: Fold Change.
| No | Upregulated Genes | Downregulated Genes | ||||||
|---|---|---|---|---|---|---|---|---|
| FC | Gene | Function | FC | Gene | Function | |||
| 1 | 12.00 | 4.82 × 10−2 |
| cell cycle progression, apoptosis, and cellular transformation | −12.98 | 1.50 × 10−3 |
| synthesis of cholesterol, steroids and other lipids |
| 2 | 7.87 | 3.91 × 10−2 |
| cell cycle regulation | −4.46 | 4.15 × 10−2 |
| TGF-beta ligant |
| 3 | 5.79 | 4.16 × 10−2 |
| TNF signaling (REACTOME) and Regulation of TP53 Activity | −3.58 | 2.80 × 10−3 |
| the protein encoded by this gene is involved in the attachment of osteoclasts to the mineralized bone matrix |
| 4 | 5.66 | 3.79 × 10−2 |
| anti-apoptotic effects of insulin-like growth factor-1 | −3.19 | 3.00 × 10−4 |
| regulation of lipid metabolism |
| 5 | 5.29 | 6.50 × 10−3 |
| involved in DNA replication | −2.72 | 6.80 × 10−3 |
| steroid, fatty acid, and xenobiotic compounds oxidation |
| 6 | 4.24 | 3.51 × 10−7 |
| megakaryocyte development and platelet production and response to elevated platelet cytosolic Ca2+ | −2.59 | 1.20 × 10−3 |
| xenobiotic metabolism |
| 7 | 4.12 | 5.54 × 10−5 |
| breakdown of DNA during apoptosis | −2.51 | 3.90 × 10−3 |
| intracellular signaling |
| 8 | 4.01 | 6.13 × 10−6 |
| receptor with an affinity for mannose and fucose | −2.51 | 1.01 × 10−7 |
| activation of cAMP-Dependent PKA (glucose homeostasis) pathways |
| 9 | 3.95 | 2.56 × 10−5 |
| vascular endothelial growth factor (VEGF) | −2.49 | 1.59 × 10−2 |
| cell grown and differentiation, and extracellular matrix formation. |
| 10 | 3.57 | 4.00 × 10−4 |
| involved in the phagocytosis of immune complexes and in the regulation of antibody production by B-cells | −2.47 | 9.30 × 10−3 |
| arachidonic acid epoxygenase activity |
| 11 | 3.49 | 2.00 × 10−4 |
| downregulation in hepatocarcinom | −2.3 | 2.66 × 10−2 |
| cAMP and cGMP regulation |
| 12 | 3.34 | 2.80 × 10−3 |
| synthesis of bile acids and bile salts and cytochrome P450 | −2.29 | 4.72 × 10−2 |
| extracellular matrix |
| 13 | 3.34 | 2.06 × 10−2 |
| steroid biosynthetic process | −2.21 | 1.48 × 10−2 |
| cell growth |
| 14 | 3.29 | 2.29 × 10−2 |
| circadian rhythm | −2.18 | 1.71 × 10−2 |
| involved with liver disease and autoimmune hepatitis |
| 15 | 3.14 | 3.04 × 10−2 |
| among its related pathways are ectoderm differentiation | −2.18 | 3.00 × 10−4 |
| cell transportation |
| 16 | 3.05 | 6.80 × 10−3 |
| adaptive immunity | −2.09 | 2.10 × 10−3 |
| hormone regulation |
| 17 | 3.04 | 1.90 × 10−3 |
| transportation of molecules and NRF2 pathway | −2.02 | 2.30 × 10−3 |
| lipid homeostasis |
| 18 | 3 | 1.00 × 10−4 |
| immune response | −2.01 | 2.49 × 10−2 |
| acetyl-CoA synthesis |
| 19 | 2.96 | 2.00 × 10−3 |
| TGF-beta component | −1.99 | 2.57 × 10−2 |
| glucose homeostasis |
| 20 | 2.96 | 1.00 × 10−3 |
| organization and signaling (sugar-dependent mechanism) cellular | −1.98 | 1.10 × 10−3 |
| IL-2 Pathway/Imune sistem |
| 21 | 2.86 | 1.40 × 10−3 |
| receptor with an affinity for galactose and fucose | −1.96 | 2.00 × 10−4 |
| phosphatidic acid transfer activity |
| 22 | 2.82 | 3.85 × 10−5 |
| galactose and carbohydrate binding | −1.95 | 6.70 × 10−3 |
| nuclear protein |
| 23 | 2.74 | 2.00 × 10−3 |
| activates the oncogenes HRAS and RAP1A. | −1.93 | 2.27 × 10−2 |
| cell regulation |
| 24 | 2.73 | 3.00 × 10−3 |
| autoantigen in T2DM (or IDDM) | −1.92 | 3.40 × 10−3 |
| fatty acid synthesis |
| 25 | 2.7 | 9.00 × 10−4 |
| activated macrophage/microglia WAP domain protein | −1.92 | 4.31 × 10−2 |
| lipid homeostasis |
Relative abundance of selected bacteria in the cecal microbiome in male C57BL/6J mice fed HF+CP after 10 weeks. a, b Groups not sharing the same lowercase letters indicate that one-way ANOVA found significant differences between groups (p < 0.05).
| Phyla | LF | HF | HF+CP | |
|---|---|---|---|---|
| p__Actinobacteria | 6.45 ± 0.64 b | 16.59 ± 0.43 a | 7.02 ± 0.60 b | 0.001 |
| p__Bacteroidetes | 29.18 ± 0.28 a | 13.76 ± 0.66 c | 19.41 ± 0.47 b | 0.0001 |
| p__Firmicutes | 44.26 ± 4.19 | 52.75 ± 0.66 | 46.13 ± 0.43 | 0.46 |
| p__Proteobacteria | 1.77 ± 0.38 | 1.68 ± 0.03 | 2.20 ± 0.03 | 0.73 |
| p__Verrucomicrobia | 18.34 ± 2.99 | 15.22 ± 0.57 | 25.23 ± 0.33 | 0.25 |
|
| ||||
| g__Akkermansia | 18.31 ± 2.97 | 15.22 ± 0.57 | 25.23 ± 0.49 | 0.25 |
| o__Clostridiales | 16.90 ± 6.04 | 11.98 ± 2.17 | 20.53 ± 0.27 | 0.15 |
| g__Bacteroides | 9.66 ± 0.49 | 8.22 ± 0.45 | 11.99 ± 1.06 | 0.11 |
| o__Bacteroidales;S24-7 | 19.48 ± 0.24 a | 5.54 ± 0.25 b | 7.42 ± 0.35 b | <0.0001 |
| f__Coriobacteriaceae | 6.38 ± 0.64 b | 16.45 ± 0.43 a | 6.86 ± 0.87 b | 0.001 |
| g__Oscillospira | 4.08 ± 0.26 b | 4.63 ± 0.24 b | 7.18 ± 0.61 a | 0.025 |
| g__Lactococcus | 4.01 ± 0.41 b | 6.84 ± 0.27 a | 2.54 ± 0.08 b | 0.008 |
| f__Ruminococcaceae | 1.91 ± 0.14 | 3.26 ± 0.28 | 1.93 ± 0.36 | 0.10 |
| g__Sutterella | 1.77 ± 0.38 | 1.68 ± 0.03 | 2.20 ± 0.04 | 0.73 |
| Others | 17.51 ± 4.08 | 26.18 ± 0.74 | 14.11 ± 0.16 | 0.28 |
Figure 5Bacteroids:Firmicutes ratio of microbiome of male C57BL/6J mice fed a low fat (LF) diet (A), a high fat (HF) diet (B), or a HF plus cashew pseudofruit (HF+CP) diet.